• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同 Aβ 聚集物作为抗原对静脉注射免疫球蛋白中针对淀粉样蛋白-β40/42 的天然自身抗体测量的影响。

Effect of Different Aβ Aggregates as Antigen on the Measure of Naturally Occurring Autoantibodies against Amyloid-β40/42 in IVIG.

机构信息

Institute of Blood Transfusion, Chinese Academy of Medical Sciences & Peking Union Medical College, Chengdu, China.

School of Materials Science and Engineering, Southwest Petroleum University, Chengdu, China.

出版信息

Curr Alzheimer Res. 2019;16(14):1290-1299. doi: 10.2174/1567205017666200102151731.

DOI:10.2174/1567205017666200102151731
PMID:31894747
Abstract

BACKGROUND

The specific Intravenous Immunoglobulin (IVIG) for Alzheimer's Disease (AD) is developing, which contains a high level of naturally occurring autoantibodies against amyloid-β (nAbs-Aβ), and the measure of nAbs-Aβ content is greatly essential. Though Enzyme-Linked Immunosorbent Assay (ELISA) has been widely used in detecting the nAbs-Aβ content, the impact of Aβ aggregates species chosen as antigen in ELISA on this measure has not been evaluated.

OBJECTIVE

To clarify the influence of different Aβ40/42 aggregates as antigen during ELISA on the content of nAbs-Aβ40/42 measured in IVIG.

METHOD

Preparation of various Aβ40/42 aggregates was performed by different aggregation solutions and various lengths of time, and analyzed by western blot. Different Aβ40/42 aggregates as antigen were adopted to measure the nAbs-Aβ40/42 content in IVIG by ELISA, and the control was carried out to reduce interference of nonspecific binding. The Bonferroni and Dunnett's T3 were used for statistical analysis.

RESULTS

The duration for the formation of Aβ40/42 aggregates had more effect on detecting nAbs-Aβ40/42 content in IVIG than the aggregation solution. Higher content of nAbs-Aβ40/42 in the same IVIG was displayed when measured with Aβ40/42 aggregates at day 3, instead of at day 0.5 and day 7.0. The nAbs- Aβ40/42 contents in the same IVIG measured with Aβ40/42 aggregates prepared in different solutions were obviously different, but there was no significant regularity among them.

CONCLUSION

The nAbs-Aβ40/42 content in the same IVIG is significantly different when measured with Aβ40/42 aggregated under different conditions. The nAbs-Aβ40/42 content in IVIG by antigen-dependent measures, like ELISA, is uncertain.

摘要

背景

针对阿尔茨海默病(AD)的特定静脉注射免疫球蛋白(IVIG)正在研发中,其中含有高水平的天然抗淀粉样蛋白-β(Aβ)自身抗体(nAbs-Aβ),因此,nAbs-Aβ 含量的测量至关重要。尽管酶联免疫吸附测定(ELISA)已广泛用于检测 nAbs-Aβ 含量,但 ELISA 中作为抗原的 Aβ 聚集物种类对这一测量的影响尚未得到评估。

目的

阐明 ELISA 中使用不同的 Aβ40/42 聚集物作为抗原对 IVIG 中 nAbs-Aβ40/42 含量的影响。

方法

采用不同的聚集溶液和不同的时间制备各种 Aβ40/42 聚集物,并通过 Western blot 进行分析。采用不同的 Aβ40/42 聚集物作为抗原,通过 ELISA 测量 IVIG 中的 nAbs-Aβ40/42 含量,并进行了对照实验以减少非特异性结合的干扰。采用 Bonferroni 和 Dunnett's T3 进行统计分析。

结果

Aβ40/42 聚集物形成的时间对检测 IVIG 中 nAbs-Aβ40/42 含量的影响大于聚集溶液。在第 3 天测量时,同一 IVIG 中显示出更高的 nAbs-Aβ40/42 含量,而在第 0.5 天和第 7.0 天则较低。用不同溶液制备的 Aβ40/42 聚集物测量同一 IVIG 中的 nAbs-Aβ40/42 含量明显不同,但彼此之间没有明显的规律。

结论

用不同条件下制备的 Aβ40/42 聚集物测量同一 IVIG 中的 nAbs-Aβ40/42 含量差异显著。ELISA 等基于抗原的方法测量 IVIG 中的 nAbs-Aβ40/42 含量不确定。

相似文献

1
Effect of Different Aβ Aggregates as Antigen on the Measure of Naturally Occurring Autoantibodies against Amyloid-β40/42 in IVIG.不同 Aβ 聚集物作为抗原对静脉注射免疫球蛋白中针对淀粉样蛋白-β40/42 的天然自身抗体测量的影响。
Curr Alzheimer Res. 2019;16(14):1290-1299. doi: 10.2174/1567205017666200102151731.
2
Naturally occurring autoantibodies against Aβ oligomers exhibited more beneficial effects in the treatment of mouse model of Alzheimer's disease than intravenous immunoglobulin.与静脉注射免疫球蛋白相比,天然存在的针对β淀粉样蛋白寡聚体的自身抗体在阿尔茨海默病小鼠模型的治疗中表现出更有益的效果。
Neuropharmacology. 2016 Jun;105:561-576. doi: 10.1016/j.neuropharm.2016.02.015. Epub 2016 Feb 18.
3
Comparison of intravenous immunoglobulins for naturally occurring autoantibodies against amyloid-beta.比较静脉注射免疫球蛋白治疗天然存在的针对淀粉样β的自身抗体。
J Alzheimers Dis. 2010;20(1):135-43. doi: 10.3233/JAD-2010-1353.
4
Extending the functional characteristics of naturally occurring autoantibodies against β-Amyloid, Prion Protein and α-Synuclein.扩展天然存在的针对β-淀粉样蛋白、朊病毒蛋白和α-突触核蛋白的自身抗体的功能特性。
PLoS One. 2018 Aug 29;13(8):e0202954. doi: 10.1371/journal.pone.0202954. eCollection 2018.
5
Naturally occurring autoantibodies against β-Amyloid.天然存在的针对β-淀粉样蛋白的自身抗体。
Adv Exp Med Biol. 2012;750:91-9. doi: 10.1007/978-1-4614-3461-0_7.
6
Concentrations of antibodies against β-amyloid 40/42 monomer and oligomers in Chinese intravenous immunoglobulins.中国静脉注射免疫球蛋白中抗β-淀粉样蛋白40/42单体和寡聚体抗体的浓度。
J Pharm Biomed Anal. 2017 May 10;138:277-282. doi: 10.1016/j.jpba.2017.02.024. Epub 2017 Feb 17.
7
Comparison of ELISA measurements of anti-Aβ concentrations and percentages of specific binding to Aβ between unfractionated intravenous immunoglobulin products and their purified anti-Aβ antibodies.对比未经分离的静脉注射免疫球蛋白制品及其纯化的抗 Aβ 抗体的 ELISA 法测量的抗 Aβ 浓度和对 Aβ 的特异性结合百分比。
Immunol Lett. 2013 Jul-Aug;154(1-2):7-11. doi: 10.1016/j.imlet.2013.07.008. Epub 2013 Aug 6.
8
Naturally occurring autoantibodies against beta-amyloid: investigating their role in transgenic animal and in vitro models of Alzheimer's disease.天然产生的针对β-淀粉样蛋白的自身抗体:研究其在阿尔茨海默病转基因动物和体外模型中的作用。
J Neurosci. 2011 Apr 13;31(15):5847-54. doi: 10.1523/JNEUROSCI.4401-10.2011.
9
The Diagnostic Potential of Circulating Autoantibodies to Amyloid-β in Alzheimer's Disease.循环自身抗体在阿尔茨海默病中对淀粉样β的诊断潜力。
J Alzheimers Dis. 2023;94(2):537-546. doi: 10.3233/JAD-230252.
10
Immunological origin and functional properties of catalytic autoantibodies to amyloid beta peptide.淀粉样β肽催化自身抗体的免疫起源和功能特性。
J Clin Immunol. 2010 May;30 Suppl 1(Suppl 1):S43-9. doi: 10.1007/s10875-010-9414-5.

引用本文的文献

1
Efficacy and safety of blood derivatives therapy in Alzheimer's disease: a systematic review and meta-analysis.血液衍生物疗法治疗阿尔茨海默病的疗效和安全性:系统评价和荟萃分析。
Syst Rev. 2022 Nov 29;11(1):256. doi: 10.1186/s13643-022-02115-y.